Out of stock
Evista (raloxifene hydrochloride) is a selective estrogen receptor modulator (SERM). It is used to treat osteoporosis and is not a hormone.
Evista Treats Thin Bones and Lowers Risk of Invasive Breast Cancer:
Evista is used for the prevention and treatment of osteoporosis (bone thinning) in postmenopausal women. In 2007, it was approved for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer. Evista is not a breast cancer treatment drug, but it can be used to help prevent cases of invasive estrogen-receptor-positive breast cancer. It does not reduce your risk of recurrence for invasive breast cancer.